These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9850046)

  • 21. Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.
    Dairkee SH; Nicolau M; Sayeed A; Champion S; Ji Y; Moore DH; Yong B; Meng Z; Jeffrey SS
    Oncogene; 2007 Sep; 26(43):6269-79. PubMed ID: 17471242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.
    Mezzelani A; Alasio L; Bartoli C; Bonora MG; Pierotti MA; Rilke F; Pilotti S
    Br J Cancer; 1999 May; 80(3-4):519-25. PubMed ID: 10408862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study.
    Hirashima N; Takahashi W; Yoshii S; Yamane T; Ooi A
    Mod Pathol; 2001 Jun; 14(6):556-62. PubMed ID: 11406656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells.
    Kudoh M; Knee DA; Takayama S; Reed JC
    Cancer Res; 2002 Mar; 62(6):1904-9. PubMed ID: 11912172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal.
    Diehl KM; Grewal N; Ethier SP; Woods-Ignatoski KM
    J Surg Res; 2007 Sep; 142(1):162-9. PubMed ID: 17612563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of numerical aberrations in chromosomes by fluorescence in situ hybridization in fine needle aspirates in the preoperative diagnosis of cancer].
    Noguchi S; Tsukamoto F; Miyoshi Y; Inaji H; Watatani M; Sasa M; Inazawa J; Takami S
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2127-30. PubMed ID: 10635294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
    Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
    Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG; Schelling ME; Hosick HL
    Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis.
    Goldberg GS; Jin Z; Ichikawa H; Naito A; Ohki M; El-Deiry WS; Tsuda H
    Cancer Res; 2001 Feb; 61(4):1334-7. PubMed ID: 11245430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
    Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6.
    Kurebayashi J; Otsuki T; Tang CK; Kurosumi M; Yamamoto S; Tanaka K; Mochizuki M; Nakamura H; Sonoo H
    Br J Cancer; 1999 Feb; 79(5-6):707-17. PubMed ID: 10070858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.